ASTELLAS PHARMA UNSP.ADR (YPHA) — Defensive Interval Ratio
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Defensive Interval Ratio of 228 days as of March 2025. Defensive assets of €662.47 Billion (cash €-, short-term investments €29.94 Billion, receivables €632.52 Billion) cover 228 days of daily cash needs of €2.91 Billion/day. See ASTELLAS PHARMA UNSP.ADR working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ASTELLAS PHARMA UNSP.ADR Defensive Interval Ratio (2022–2025)
This chart shows how ASTELLAS PHARMA UNSP.ADR's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2025, the ratio stands at 228 days, meaning defensive assets of €662.47 Billion can fund 228 days of operations without new revenue. See YPHA equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ASTELLAS PHARMA UNSP.ADR market cap and net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 228 days | €662.47 Billion | €2.91 Billion/day | €- | €29.94 Billion | ▲ +68 days |
| 2024 | 160 days | €563.77 Billion | €3.52 Billion/day | €- | €28.78 Billion | ▼ -65 days |
| 2023 | 225 days | €447.75 Billion | €1.99 Billion/day | €- | €19.78 Billion | ▲ +11 days |
| 2022 | 214 days | €403.76 Billion | €1.88 Billion/day | €- | €21.30 Billion | — |